7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 
      
    		                                               
      cash flows from operating activities
    		                                               
      net income
    		-6,027,000 -30,825,000 -48,632,000  -46,297,000 -67,408,000 -68,709,000  -24,269,000 -21,954,000 -60,763,000 -12,042,000 -32,759,000 -33,974,000 23,594,000 73,061,000 -40,191,000 52,248,000 -2,487,000 -13,691,000 -12,550,000 -35,018,000 -8,074,000 -26,912,000 -10,225,000 -16,033,000 80,045,000 -18,199,000 3,151,000 -25,868,000 -29,493,000  -15,563,000 -6,884,000 -14,635,000  -8,077,000 47,165,000 -6,398,000 7,757,000 -10,037,000 -8,868,000 -6,444,000 -1,349,000 -6,278,000 -5,044,000 -3,751,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                               
      depreciation and amortization
    		2,589,000 2,653,000 2,693,000 2,994,000 3,054,000 3,024,000 3,035,000 3,228,000 3,140,000 2,885,000 2,245,000 2,159,000 2,238,000 2,224,000 2,178,000 2,107,000 1,993,000 1,753,000 1,638,000 1,532,000 1,446,000 1,443,000 1,373,000 1,225,000 1,070,000 1,007,000 996,000 883,000 816,000 822,000 730,000  556,000 454,000 410,000  371,000 346,000 282,000 345,000 274,000 254,000 240,000 261,000 135,000 166,000 320,000 
      accretion of discount on marketable debt securities
    		-1,652,000 637,000 -2,126,000  -3,467,000 -4,436,000 -5,601,000                                         
      stock-based compensation
    		10,092,000 10,737,000 12,213,000 12,332,000 12,338,000 17,190,000 11,421,000 14,697,000 12,896,000 13,563,000 12,599,000 12,745,000 12,760,000 12,603,000 10,805,000 10,389,000 8,943,000 9,350,000 8,293,000 8,558,000 8,318,000 8,231,000 6,512,000 7,178,000 9,514,000 9,303,000 5,856,000 5,075,000 6,120,000 4,882,000 4,471,000  3,604,000 3,449,000 3,158,000  1,865,000 2,033,000 1,960,000 1,483,000 1,086,000 1,193,000 1,107,000 751,000 471,000 361,000 278,000 
      gain on sale of marketable securities
    		407,000                                               
      change in fair value of marketable equity securities
    		-44,608,000                                               
      asset impairment charges
    		1,565,000 1,858,000 4,865,000                                             
      non-cash royalty revenue related to the sale of future royalties
    		-20,997,000                                               
      non-cash interest expense on liabilities related to the sale of future royalties
    		7,663,000                                               
      changes in operating assets and liabilities:
    		                                               
      accounts receivable
    		19,896,000 -8,769,000 23,405,000 -33,758,000 11,868,000           -45,839,000 -5,720,000 -2,300,000 -1,082,000 -1,909,000 -609,000 -2,100,000 14,749,000 -17,224,000 5,781,000 127,611,000 -127,489,000 -7,725,000 -1,180,000 -184,000 44,000  14,045,000 -7,938,000 1,678,000  147,266,000 -149,706,000 -604,000 364,000 45,000 -42,000 2,555,000 -2,947,000    
      prepaid expenses and other assets
    		5,257,000 -1,553,000 5,057,000 2,010,000 3,840,000 -7,250,000 1,559,000 3,511,000 465,000 -77,000 1,204,000 -397,000 -3,152,000 3,277,000 906,000  -5,290,000 -1,430,000 -3,438,000  -2,786,000 -914,000 71,000  3,775,000 -1,874,000 942,000  -67,000 -5,425,000 -1,043,000  756,000 -3,262,000 -1,465,000  -1,257,000 -348,000 -683,000         
      accounts payable
    		-9,454,000 4,378,000 -568,000 -2,011,000 2,932,000 -173,000 2,097,000 -1,053,000 870,000 -1,245,000 5,254,000 -4,530,000 -1,129,000 3,842,000 -2,096,000 4,870,000 2,019,000 -551,000 -1,291,000 -4,155,000 2,596,000 200,000 124,000 1,884,000 -689,000 3,508,000 1,689,000 -2,186,000 1,067,000 -3,607,000 1,654,000  -778,000 3,105,000 395,000  -360,000 3,403,000 -2,109,000 1,293,000 2,030,000 688,000 699,000 -407,000    
      accrued expenses
    		4,223,000 5,785,000 -3,154,000 -6,190,000 5,850,000 6,066,000 -10,073,000 -908,000 6,032,000 3,300,000 -3,588,000 -561,000 2,941,000 3,736,000 -6,831,000 -2,665,000 4,780,000 4,815,000 -5,090,000 6,222,000 2,224,000 1,865,000 -1,703,000 1,163,000 1,606,000 521,000 -3,957,000 3,990,000 -251,000 1,312,000 -869,000  652,000 -2,518,000 -190,000  3,259,000 886,000 -1,243,000 -183,000 1,280,000 851,000 -523,000 487,000   72,000 
      operating lease
    		13,000 709,000 168,000                                             
      other assets and liabilities
    		216,000                                               
      net cash from operating activities
    		-30,817,000 -36,369,000 -16,220,000 -55,575,000 -26,018,000 -65,337,000 -55,258,000 181,206,000 -27,281,000 -38,200,000 -30,614,000 -24,431,000 -1,168,000 44,269,000 5,815,000 61,790,000 -39,023,000 -9,654,000 -29,966,000 17,084,000 -3,866,000 -27,682,000 9,460,000 -19,577,000 -6,477,000 109,156,000 -18,728,000 -16,781,000 -10,311,000 -28,419,000 -24,245,000  -3,509,000 -12,788,000 -10,720,000  134,074,000 -9,369,000 -14,300,000 -3,845,000 39,520,000 -6,916,000 -2,093,000 -5,864,000    
      capex
    		-183,000 -383,000 -1,444,000 -1,664,000 -1,275,000 -3,026,000 -132,000 -980,000 -2,832,000 -3,853,000 -10,783,000 -9,966,000 -14,085,000 -12,354,000 -2,089,000 -6,320,000 -2,745,000 -2,283,000 -1,951,000 -3,149,000 -4,695,000 -622,000 -2,073,000 -2,910,000 -2,576,000 -1,452,000 -415,000 -2,787,000 -1,009,000 -1,070,000 -2,346,000  -2,578,000 -762,000 -494,000  -740,000 -176,000 -317,000 -206,000 -609,000 -540,000 -575,000 -220,000    
      free cash flows
    		-31,000,000 -36,752,000 -17,664,000 -57,239,000 -27,293,000 -68,363,000 -55,390,000 180,226,000 -30,113,000 -42,053,000 -41,397,000 -34,397,000 -15,253,000 31,915,000 3,726,000 55,470,000 -41,768,000 -11,937,000 -31,917,000 13,935,000 -8,561,000 -28,304,000 7,387,000 -22,487,000 -9,053,000 107,704,000 -19,143,000 -19,568,000 -11,320,000 -29,489,000 -26,591,000  -6,087,000 -13,550,000 -11,214,000  133,334,000 -9,545,000 -14,617,000 -4,051,000 38,911,000 -7,456,000 -2,668,000 -6,084,000    
      cash flows from investing activities
    		                                               
      purchase of marketable debt securities
    		-84,235,000            -110,910,000                                   
      purchase of property and equipment
    		-183,000 -383,000 -1,444,000 -1,664,000 -1,275,000 -3,026,000 -132,000 -980,000 -2,832,000 -3,853,000 -10,783,000 -9,966,000 -14,085,000 -12,354,000 -2,089,000 -6,320,000 -2,745,000 -2,283,000 -1,951,000 -3,149,000 -4,695,000 -622,000 -2,073,000 -2,910,000 -2,576,000 -1,452,000 -415,000 -2,787,000 -1,009,000 -1,070,000 -2,346,000  -2,578,000 -762,000 -494,000  -740,000 -176,000 -317,000 -206,000 -609,000 -540,000 -575,000 -220,000    
      purchase of patents
    		                                               
      proceeds from sales of marketable equity securities
    		379,000                                               
      proceeds from sales and maturities of marketable debt securities
    		98,707,000                                               
      net cash from investing activities
    		14,668,000 40,476,000 13,668,000 57,252,000 -163,458,000 66,016,000 32,318,000 -203,130,000 45,326,000 -1,405,000 48,144,000 24,548,000 3,125,000 -75,639,000 -71,759,000 7,860,000 -38,848,000 -53,309,000 38,048,000 78,779,000 -50,560,000 59,408,000 12,565,000 15,727,000 22,060,000 -102,430,000 13,673,000 6,866,000 5,862,000 -190,169,000 12,674,000  4,933,000 9,351,000 8,727,000  -127,665,000 8,623,000 9,660,000 -41,690,000 6,933,000 -101,291,000 -49,058,000 -587,000    
      cash flows from financing activities
    		                                               
      proceeds from the exercises of stock options
    		0 0 2,974,000                                             
      proceeds from issuance of common stock under the employee stock purchase plan
    		0    0    0    0    0    0    0    0    1,000    0    0    -7,000   
      proceeds from issuance of common stock and pre-funded warrants
    		   0                                            
      common stock and pre-funded warrants issuance costs
    		   0                                            
      cash paid to acquire noncontrolling interest
    		0 0 -1,725,000                                             
      net cash from financing activities
    		0 662,000 1,249,000 10,169,000 187,740,000 -943,000 186,000 22,983,000 356,000 1,921,000 922,000 1,171,000 1,287,000 2,513,000 731,000 32,630,000 3,229,000 1,840,000 5,339,000 9,587,000 2,986,000 4,000,000 1,471,000 2,973,000 3,049,000 3,973,000 667,000 1,165,000 4,153,000 2,308,000 246,615,000  990,000 1,096,000 1,026,000  501,000 473,000 200,000 387,000 114,000 330,000 115,550,000 177,000 -2,000 131,000 2,000 
      net decrease in cash, cash equivalents, and restricted cash
    		  -1,303,000  -1,736,000                                           
      cash, cash equivalents, and restricted cash, beginning of period
    		0 0 41,262,000  0 0 54,170,000                                         
      cash, cash equivalents, and restricted cash, end of period
    		-16,149,000 4,769,000 39,959,000  -1,736,000 -264,000 31,416,000                                         
      supplemental disclosure of cash flow information
    		                                               
      interest paid
    		2,000 1,000 1,000                                             
      income taxes paid
    		359,000                                               
      net increase in cash, cash equivalents, and restricted cash
    		      -22,754,000                                         
      gain on sale of marketable debt securities
    		    0 0 -3,000                                         
      change in fair value of equity securities
    		  -941,000 30,974,000 -9,254,000 12,027,000 -2,325,000 -13,238,000 11,023,000 -288,000 2,898,000 -28,110,000 -5,298,000 6,545,000 3,429,000 18,218,000 -1,505,000                               
      non-cash royalty revenue
    		  -18,232,000                                             
      non-cash interest expense on liability related to the sale of future royalties
    		  8,664,000                                             
      loss on disposal of assets
    		   1,571,000 0 0 6,000 -1,000 1,000 0 1,379,000 13,000   117,000 445,000    0 -1,000   0 3,000                       
      others
    		  368,000                                             
      purchase of marketable securities
    		  -103,873,000 -54,210,000 -281,714,000 -122,598,000 -136,532,000 -338,425,000 -167,765,000 -181,487,000 -95,228,000    -88,764,000 -121,771,000 -156,367,000 -147,320,000 -84,139,000 -166,348,000 -174,991,000 -159,842,000 -142,477,000 -144,681,000 -107,675,000 -194,643,000 -49,856,000 -46,714,000 -45,317,000 -254,112,000 -31,697,000  -15,763,000 -26,452,000 -6,988,000  -195,024,000 9,217,000 -16,340,000 -47,309,000 -20,161,000 -100,415,000 -47,913,000     
      proceeds from maturities of marketable securities
    		  118,985,000  117,975,000 188,024,000 159,942,000               220,801,000 157,653,000  133,079,000 94,778,000 64,995,000                     
      proceeds from sale of marketable securities
    		    0 0 9,969,000                                         
      consolidated net income
    		                                               
      (accretion of discount) amortization of premium on marketable debt securities
    		        -3,866,000                                       
      abandonment of capitalized intangible assets
    		   150,000 1,395,000 369,000 415,000 470,000 203,000 273,000 321,000 179,000 284,000 736,000 311,000 207,000 417,000 117,000 193,000 132,000 236,000 139,000 28,000 106,000 25,000 32,000 58,000 121,000 68,000 45,000 5,000  48,000 216,000 9,000  62,000 36,000 9,000 16,000 226,000 17,000 37,000 13,000 365,000 121,000 10,000 
      gain on sale of available-for-sale marketable debt securities
    		                                               
      equity received in connection with license agreement
    		                   -22,071,000 0 0 -4,589,000                         
      impairment on equity securities
    		   0 0 -220,000 20,650,000      0                                   
      noncash royalty revenue related to sale of future royalties
    		                                               
      noncash interest expense
    		                                               
      interest receivable from marketable debt securities
    		   -310,000 -1,426,000 -395,000 -1,310,000 -1,141,000 -307,000 172,000 248,000 -138,000 56,000 -197,000 -251,000                                 
      income taxes
    		   1,298,000 0                804,000    -400,000 704,000 900,000  1,000 0 -157,000  -455,000 280,000 110,000  -1,381,000           
      lease liabilities and rou assets
    		   167,000 948,000 213,000 213,000 2,513,000 155,000 251,000 331,000 1,805,000 13,260,000 6,175,000 1,736,000        -54,000 -49,000 -45,000 194,000 1,254,000                     
      deferred revenue
    		       -9,222,000 1,357,000 -22,239,000 -216,000 -4,866,000 -113,000 -189,000 -1,806,000 24,344,000 -6,250,000 -58,621,000 -14,794,000 48,775,000 -845,000 -1,491,000 -955,000 -1,061,000 -586,000 -14,362,000 23,061,000 0     -7,091,000 -740,000 -340,000  -7,483,000 84,493,000 -5,952,000 -14,755,000 44,406,000 -322,000 -91,000 -2,702,000    
      proceeds from maturities of marketable debt securities available-for-sale
    		                                               
      proceeds from sale of marketable debt securities available-for-sale
    		                                               
      proceeds from sale of equity securities
    		                                               
      proceeds from sale of property and equipment
    		               15,000 0                       0 0 8,000 1,000 1,000 0   
      purchase of intangible assets
    		      -929,000 -726,000 -587,000 -1,083,000 -407,000 -933,000 -780,000 -2,291,000 -906,000 -334,000 -1,024,000 -1,252,000 -72,000 -1,086,000 -676,000 -929,000 -538,000 -753,000 -768,000 -1,113,000 -1,051,000 -633,000 -420,000 -493,000 -389,000  -428,000 -390,000 -702,000  -446,000 -418,000 -343,000 -525,000 -305,000 -344,000 -571,000 -368,000    
      conversion of convertible note
    		                                               
      proceeds from issuance of common stock upon exercise of stock awards
    		   3,701,000 685,000 140,000 1,787,000 1,455,000 356,000 679,000 922,000 276,000 1,287,000 1,316,000 731,000 2,810,000 3,229,000 903,000 5,339,000 8,885,000 2,986,000 3,275,000 1,471,000 2,314,000 3,049,000 3,239,000 667,000 549,000 4,153,000 1,805,000 1,110,000  989,000 654,000 1,026,000  501,000 247,000 200,000 11,000 114,000 249,000 180,000 1,000   4,000 
      proceeds from issuance of common stock from employee stock purchase plan
    		                                               
      proceeds from sale of future royalties
    		                                               
      proceeds from non-controlling interest
    		                                               
      cash, cash equivalents, and restricted cash, beginning of year
    		                                               
      cash, cash equivalents, and restricted cash, end of year
    		                                               
      equity received in connection with license agreements
    		        0                                       
      non-cash interest expense
    		    782,000 833,000 1,067,000                                         
      deferred income
    		    -8,581,000 -6,902,000 -9,410,000                                         
      sale of equity securities
    		    2,403,000                                           
      purchase of patents, licenses, and other intangible assets
    		    -847,000                                           
      reduction of liability for sale of future royalties
    		    -2,124,000                                           
      accounts receivable and contract asset
    		      1,710,000  -34,981,000 -157,000 9,135,000  9,408,000 38,920,000 -26,820,000                                 
      repayment of liability for sale of future royalties
    		      -1,601,000                                         
      cash paid during the period for:
    		                                               
      interest
    		      11,000 1,000 7,000 7,000 7,000 0 4,000 5,000 4,000 1,000 4,000 5,000 4,000 0 4,000 5,000 6,000 0 4,000 3,000 4,000 7,000 3,000 3,000 3,000  3,000 2,000 3,000           3,000 2,000 
      supplemental disclosures of non-cash activities
    		                                               
      unrealized gain on marketable securities
    		      -1,445,000  1,151,000 1,766,000 3,327,000    -5,611,000   -113,000 23,000  -916,000                           
      rou assets obtained
    		      7,166,000                                         
      reconciliation of cash, cash equivalents, and restricted cash reported in the balance sheets
    		                                               
      cash and cash equivalents
    		      31,034,000                                         
      restricted cash
    		      382,000                                         
      total cash, cash equivalents, and restricted cash shown in the statement of cash flows
    		      31,416,000                                         
      amortization of premium (accretion of discount) on marketable securities
    		               528,000 921,000 846,000 865,000                             
      equity received in connection with sale of financial assets
    		               0 0                               
      equity securities impairment
    		                                               
      accounts receivable and contract assets
    		                                               
      income tax
    		                                               
      proceeds from sale and maturities of marketable debt securities available-for-sale
    		                                               
      conversion (purchase) of convertible note
    		                                               
      exercise of stock options
    		                                               
      proceeds from issuance of common stock
    		                           0 0 0 260,245,000         0 0 0 122,906,000     
      supplemental disclosures of cash flow information
    		                                               
      cash paid for:
    		                                               
      taxes
    		                                               
      supplemental schedule of noncash activities
    		                                               
      net unrealized gain on marketable securities available-for-sale
    		                                      619,000         
      addition of right-of-use asset
    		                                               
      proceeds from maturities and sale of marketable securities
    		        216,510,000 185,018,000 154,562,000    20,000,000  122,130,000 97,542,000 124,210,000                             
      supplemental disclosures of non-cash investing activities
    		                                               
      net decrease in cash and cash equivalents
    		            3,244,000                     -2,341,000 -967,000             
      cash and cash equivalents, beginning of period
    		         0 53,942,000  0 0 143,480,000  0 0 163,544,000  0 0 50,312,000  0 0 26,246,000  0 0 16,528,000  0 0 14,528,000  0 0 12,590,000  0 0 54,649,000     
      cash and cash equivalents, end of period
    		         -37,684,000 72,394,000  3,244,000 -28,857,000 78,267,000  -74,642,000 -61,123,000 176,965,000  -51,440,000 35,726,000 73,808,000  18,632,000 10,699,000 21,858,000  -296,000 -216,280,000 251,572,000  2,414,000 -2,341,000 13,561,000  6,910,000 -273,000 8,150,000  46,567,000 -107,877,000 119,048,000     
      amortization of premium on marketable securities
    		          -1,661,000  -59,000 425,000 543,000             -462,000 -338,000 -74,000 480,000  792,000 697,000 659,000  522,000 450,000 426,000 454,000 402,000 177,000 63,000     
      net increase in cash and cash equivalents
    		          18,452,000    -65,213,000 102,280,000 -74,642,000 -61,123,000 13,421,000 105,450,000 -51,440,000 35,726,000 23,496,000 -877,000 18,632,000 10,699,000 -4,388,000 -8,750,000 -296,000 -216,280,000 235,044,000 2,894,000    -259,000   -4,440,000 -45,148,000 46,567,000 -107,877,000 64,399,000     
      gain on sale of marketable securities available-for-sale
    		                                               
      cash redemption of equity received in connection with license agreement
    		                                               
      contract asset and deposits
    		               0 121,000 12,000,000 -62,000 -12,454,000                            
      proceeds from sale and maturities of marketable securities available-for-sale
    		                                      26,660,000         
      cash and cash equivalents, beginning of year
    		                                               
      cash and cash equivalents, end of year
    		                                               
      purchase of equity securities
    		                                               
      proceeds from maturities of marketable debt securities
    		                                               
      ​
    		                                               
      unrealized loss on marketable debt securities
    		            -931,000                                   
      gain on disposal of assets
    		                                               
      proceeds from maturities and sale of marketable debt securities
    		                                               
      prepaid expenses and other current assets
    		                                         -392,000 -142,000     
      income tax receivable
    		                                               
      deferred rent
    		                       0 0 0 -1,513,000 -68,000 260,000 -36,000 242,000  371,000 18,000 -30,000  -9,000 -27,000 -26,000 -23,000 -22,000 64,000 553,000     
      purchase of convertible note
    		                                               
      supplemental schedule of noncash investing activities
    		                                               
      gain on sale of marketable securities available for sale
    		                    0                           
      interest receivable
    		                -314,000 185,000 311,000 55,000 221,000 699,000 215,000 -384,000 151,000 -185,000 31,000 89,000 -29,000 -286,000 -309,000  -444,000 335,000 -479,000  -701,000 119,000 41,000 -239,000 11,000 -524,000 -146,000     
      lease liabilities and right of use (rou) assets
    		                469,000 -41,000 -42,000  -58,000                           
      unrealized loss on marketable securities
    		                                               
      (gain) loss on disposal of assets
    		                                               
      change in fair value of equity security
    		                  -12,980,000 689,000 -2,772,000 -358,000 2,336,000                         
      income tax payable
    		                                               
      proceeds from repayment of loan receivable
    		                                               
      common stock issuance costs
    		                           0 0 -1,000 -14,740,000         0 0 -166,000 -7,536,000     
      accretion of discount on marketable securities
    		                    -143,000 -265,000 -573,000                         
      unrealized gain on marketable securities, net of tax
    		                      -105,000  -193,000 1,284,000 1,316,000  -730,000 593,000 -393,000  143,000 -44,000 245,000             
      loss on sale of marketable securities available-for-sale
    		                                               
      other assets
    		                                              50,000 
      proceeds from repayment of (investment in) loan receivable
    		                                               
      amortization of premium and accretion of discount on marketable securities
    		                        -1,457,000 -1,275,000 -601,000                     
      contract asset
    		                                               
      repayment of loan
    		                                               
      repayment (issuance) of loan
    		                                               
      proceeds from sale and maturities of marketable securities
    		                             65,506,000 47,020,000  23,700,000 36,955,000 16,911,000  68,545,000           
      loan receivable
    		                             0 86,000                 
      net cash provided by:
    		                                               
      operating activities
    		                                               
      investing activities
    		                                               
      financing activities
    		                                               
      net unrealized gain on marketable securities, net of tax
    		                                               
      gain on sale and maturities of marketable securities available-for-sale
    		                                               
      loss on exchange of notes for preferred stock
    		                                               
      accrued interest on convertible promissory notes
    		                                               
      proceeds from sale of series a-1 preferred stock
    		                                               
      preferred stock issuance cost
    		                                               
      payments on capital lease obligations
    		                                               
      net unrealized loss on marketable securities available-for-sale
    		                                       510,000        
      supplemental schedule of noncash financing activities
    		                                               
      settlement of notes payable for preferred stock
    		                                               
      proceeds from sale of marketable securities available-for-sale
    		                                               
      net unrealized loss on marketable securities available for sale
    		                                         55,000 35,000     
      supplemental disclosures of non-cash investing and financing activities
    		                                               
      gain from non-monetary exchange
    		                                               
      proceeds from sale of series a-1preferred stock
    		                                               
      proceeds from sale of common stock
    		                                               
      payments of initial public offering costs
    		                                               
      capitalization of licensing rights acquired in non-monetary exchange
    		                                               
      equipment acquired under capital lease
    		                                               
      proceeds from the sale of series a-1 preferred
    		                                               
      preferred stock issuance costs
    		                                               
      net increase in cash
    		                                               
      cash, beginning of period
    		                                            0 0 77,975,000 
      cash, end of period
    		                                            -5,295,000 -6,318,000 72,536,000 
      money market funds
    		                                               
      
    		                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.